GLUE
Price
$16.56
Change
-$0.67 (-3.89%)
Updated
Dec 11 closing price
Capitalization
1.08B
90 days until earnings call
Intraday BUY SELL Signals
KURA
Price
$10.52
Change
+$0.06 (+0.57%)
Updated
Dec 12, 11:45 AM (EDT)
Capitalization
910.2M
81 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GLUE vs KURA

Header iconGLUE vs KURA Comparison
Open Charts GLUE vs KURABanner chart's image
Monte Rosa Therapeutics
Price$16.56
Change-$0.67 (-3.89%)
Volume$632.82K
Capitalization1.08B
Kura Oncology
Price$10.52
Change+$0.06 (+0.57%)
Volume$2.68K
Capitalization910.2M
GLUE vs KURA Comparison Chart in %
GLUE
Daily Signal:
Gain/Loss:
KURA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
GLUE vs. KURA commentary
Dec 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLUE is a Buy and KURA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 13, 2025
Stock price -- (GLUE: $16.56 vs. KURA: $10.46)
Brand notoriety: GLUE and KURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLUE: 59% vs. KURA: 76%
Market capitalization -- GLUE: $1.08B vs. KURA: $910.2M
GLUE [@Biotechnology] is valued at $1.08B. KURA’s [@Biotechnology] market capitalization is $910.2M. The market cap for tickers in the [@Biotechnology] industry ranges from $113.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLUE’s FA Score shows that 1 FA rating(s) are green whileKURA’s FA Score has 1 green FA rating(s).

  • GLUE’s FA Score: 1 green, 4 red.
  • KURA’s FA Score: 1 green, 4 red.
According to our system of comparison, GLUE is a better buy in the long-term than KURA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLUE’s TA Score shows that 2 TA indicator(s) are bullish while KURA’s TA Score has 3 bullish TA indicator(s).

  • GLUE’s TA Score: 2 bullish, 4 bearish.
  • KURA’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both GLUE and KURA are a bad buy in the short-term.

Price Growth

GLUE (@Biotechnology) experienced а -4.06% price change this week, while KURA (@Biotechnology) price change was -12.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.68%. For the same industry, the average monthly price growth was +4.10%, and the average quarterly price growth was +64.61%.

Reported Earning Dates

GLUE is expected to report earnings on Mar 12, 2026.

KURA is expected to report earnings on Mar 03, 2026.

Industries' Descriptions

@Biotechnology (+0.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLUE($1.08B) has a higher market cap than KURA($910M). GLUE YTD gains are higher at: 138.617 vs. KURA (20.092). GLUE has higher annual earnings (EBITDA): 23.3M vs. KURA (-192.46M). KURA has more cash in the bank: 631M vs. GLUE (291M). KURA has less debt than GLUE: KURA (19.5M) vs GLUE (41.1M). GLUE has higher revenues than KURA: GLUE (178M) vs KURA (83.3M).
GLUEKURAGLUE / KURA
Capitalization1.08B910M118%
EBITDA23.3M-192.46M-12%
Gain YTD138.61720.092690%
P/E Ratio51.75N/A-
Revenue178M83.3M214%
Total Cash291M631M46%
Total Debt41.1M19.5M211%
FUNDAMENTALS RATINGS
KURA: Fundamental Ratings
KURA
OUTLOOK RATING
1..100
75
VALUATION
overvalued / fair valued / undervalued
1..100
30
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GLUEKURA
RSI
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
72%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend 5 days ago
89%
Bullish Trend 9 days ago
76%
Declines
ODDS (%)
N/A
Bearish Trend 4 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
GLUE
Daily Signal:
Gain/Loss:
KURA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HWSZX77.870.79
+1.02%
Hotchkis & Wiley Small Cap Value Z
TANDX37.470.36
+0.97%
Tandem Fund
JGICX70.800.37
+0.53%
Janus Henderson Growth And Income C
PQIPX14.480.03
+0.21%
PIMCO Dividend and Income I2
IYHIX5.95N/A
N/A
Nomura High Income Fund Class R

GLUE and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLUE has been loosely correlated with KURA. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if GLUE jumps, then KURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLUE
1D Price
Change %
GLUE100%
-3.89%
KURA - GLUE
46%
Loosely correlated
-2.61%
IMNM - GLUE
46%
Loosely correlated
-3.99%
XNCR - GLUE
41%
Loosely correlated
-0.58%
KYMR - GLUE
40%
Loosely correlated
-2.31%
NRIX - GLUE
40%
Loosely correlated
-2.75%
More

KURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KURA has been loosely correlated with XNCR. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if KURA jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KURA
1D Price
Change %
KURA100%
-2.61%
XNCR - KURA
58%
Loosely correlated
-0.58%
CRNX - KURA
55%
Loosely correlated
+2.60%
NRIX - KURA
55%
Loosely correlated
-2.75%
IMNM - KURA
55%
Loosely correlated
-3.99%
CLDX - KURA
53%
Loosely correlated
-0.89%
More